Victory Capital Management Inc Amphastar Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

$95.8 Billion
Q2 2024

A detailed history of Victory Capital Management Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 197,001 shares of AMPH stock, worth $9.43 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

197,001

Previous 212,686 7.37%

Holding current value

$9.43 Million

Previous $9.34 Million 15.62%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$38.65 - $43.48 $606,225 - $681,983	-15,685 Reduced 7.37%	197,001 $7.88 Million
Q1 2024 May 03, 2024	SELL	$42.85 - $63.45 $1.06 Million - $1.57 Million	-24,788 Reduced 10.44%	212,686 $9.34 Million
Q4 2023 Feb 05, 2024	BUY	$44.49 - $62.93 $9.48 Million - $13.4 Million	213,014 Added 870.87%	237,474 $14.7 Million
Q3 2023 Nov 06, 2023	SELL	$45.51 - $65.0 $203,702 - $290,940	-4,476 Reduced 15.47%	24,460 $1.12 Million
Q2 2023 Jul 27, 2023	SELL	$35.77 - $58.38 $529,467 - $864,140	-14,802 Reduced 33.84%	28,936 $1.66 Million
Q1 2023 May 02, 2023	BUY	$27.99 - $37.92 $186,021 - $252,016	6,646 Added 17.92%	43,738 $1.64 Million
Q4 2022 Feb 10, 2023	BUY	$27.93 - $31.27 $90,297 - $101,095	3,233 Added 9.55%	37,092 $1.04 Million
Q4 2022 Feb 09, 2023	SELL	$27.93 - $31.27 $71,724 - $80,301	-2,568 Reduced 7.05%	33,859 $948,000
Q3 2022 Nov 02, 2022	SELL	$27.56 - $37.75 $229,381 - $314,193	-8,323 Reduced 18.6%	36,427 $1.02 Million
Q2 2022 Aug 01, 2022	SELL	$29.79 - $42.29 $534,700 - $759,063	-17,949 Reduced 28.63%	44,750 $1.56 Million
Q1 2022 May 04, 2022	SELL	$22.96 - $36.45 $204,435 - $324,550	-8,904 Reduced 12.44%	62,699 $2.22 Million
Q4 2021 Feb 07, 2022	BUY	$18.14 - $23.29 $454,824 - $583,950	25,073 Added 53.89%	71,603 $1.67 Million
Q3 2021 Nov 02, 2021	BUY	$17.83 - $21.49 $480,643 - $579,305	26,957 Added 137.73%	46,530 $885,000
Q2 2021 Aug 03, 2021	BUY	$17.11 - $20.92 $5,594 - $6,840	327 Added 1.7%	19,573 $395,000
Q1 2021 May 04, 2021	BUY	$17.21 - $20.65 $97,649 - $117,168	5,674 Added 41.81%	19,246 $353,000
Q4 2020 Feb 01, 2021	BUY	$17.76 - $21.24 $18,648 - $22,302	1,050 Added 8.39%	13,572 $273,000
Q3 2020 Nov 09, 2020	SELL	$17.99 - $22.22 $12,377 - $15,287	-688 Reduced 5.21%	12,522 $235,000
Q2 2020 Aug 07, 2020	SELL	$14.25 - $22.46 $194,427 - $306,444	-13,644 Reduced 50.81%	13,210 $297,000
Q1 2020 May 04, 2020	SELL	$12.66 - $20.08 $155,718 - $246,983	-12,300 Reduced 31.41%	26,854 $399,000
Q4 2019 Feb 06, 2020	BUY	$17.07 - $20.64 $33,593 - $40,619	1,968 Added 5.29%	39,154 $755,000
Q4 2019 Feb 04, 2020	BUY	$17.07 - $20.64 $307,806 - $372,180	18,032 Added 94.14%	37,186 $703,000
Q3 2019 Nov 12, 2019	BUY	$19.12 - $22.62 $366,224 - $433,263	19,154 New	19,154 $380,000
Q3 2017 Oct 27, 2017	SELL	$14.73 - $17.99 $82,650 - $100,941	-5,611 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	5,611	5,611 $100,000

Others Institutions Holding AMPH

# of Institutions

279

Shares Held

34.2M

Call Options Held

25.5K

Put Options Held

24.8K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.35B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Amphastar Pharmaceuticals, Inc. Transaction History